Literature DB >> 6559206

MHC Class III products: an electron microscopic study of the C3 convertases of human complement.

C A Smith, C W Vogel, H J Müller-Eberhard.   

Abstract

We have reported a transmission electron microscopic study of the two C3 convertases of human complement and their precursors. The corresponding proteins and complexes of the classical and alternative pathway appear very similar. Cofactors C3b and C4b are nearly indistinguishable and display a characteristic but highly irregular substructure. C2 and Factor B are globular with diameters of 85 +/- 8 A and 80 +/- 8 A and both consist of three discrete globular domains each approximately 40 A in diameter. Bb and C2a each contain two domains connected by a short linker segment. Both domains of Bb and one domain of C2a are 42 A in diameter (28 kd), while the second domain of C2 is 47 A in diameter (39 kd). Attachment of the enzymatic subunits to cofactors occurs through one domain only.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6559206      PMCID: PMC2187187          DOI: 10.1084/jem.159.1.324

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  Comparison of the crystal structures of chymotrypsinogen-A and alpha-chymotrypsin.

Authors:  H T Wright
Journal:  J Mol Biol       Date:  1973-09-05       Impact factor: 5.469

2.  Amino acid sequence around the proposed thiolester bond of human complement component C4 and comparison with the corresponding sequences from C3 and alpha 2-macroglobulin.

Authors:  R D Campbell; J Gagnon; R R Porter
Journal:  Biosci Rep       Date:  1981-05       Impact factor: 3.840

3.  Kinetic and thermodynamic analysis of the control of C3b by the complement regulatory proteins factors H and I.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Biochemistry       Date:  1983-01-04       Impact factor: 3.162

4.  Molecular cloning and characterization of the gene coding for human complement protein factor B.

Authors:  R D Campbell; R R Porter
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

5.  Assignment of the structural gene for the third component of human complement to chromosome 19.

Authors:  A S Whitehead; E Solomon; S Chambers; W F Bodmer; S Povey; G Fey
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

6.  Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement.

Authors:  C A Smith; C W Vogel; H J Müller-Eberhard
Journal:  J Biol Chem       Date:  1982-09-10       Impact factor: 5.157

7.  The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate.

Authors:  C W Vogel; H J Müller-Eberhard
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

8.  Complete primary structure of human C4a anaphylatoxin.

Authors:  K E Moon; J P Gorski; T E Hugli
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

9.  Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.

Authors:  M K Pangburn; R D Schreiber; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

10.  Fourth component of human complement: description of a three polypeptide chain structure.

Authors:  R D Schreiber; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  15 in total

1.  New structural motifs on the chymotrypsin fold and their potential roles in complement factor B.

Authors:  H Jing; Y Xu; M Carson; D Moore; K J Macon; J E Volanakis; S V Narayana
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

2.  Structural transitions of complement component C3 and its activation products.

Authors:  Noritaka Nishida; Thomas Walz; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-15       Impact factor: 11.205

3.  The crystal structure of C2a, the catalytic fragment of classical pathway C3 and C5 convertase of human complement.

Authors:  Vengadesan Krishnan; Yuanyuan Xu; Kevin Macon; John E Volanakis; Sthanam V L Narayana
Journal:  J Mol Biol       Date:  2006-12-19       Impact factor: 5.469

Review 4.  Complement and the multifaceted functions of VWA and integrin I domains.

Authors:  Timothy A Springer
Journal:  Structure       Date:  2006-11       Impact factor: 5.006

5.  The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.

Authors:  Vengadesan Krishnan; Yuanyuan Xu; Kevin Macon; John E Volanakis; Sthanam V L Narayana
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-02-20

6.  3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase.

Authors:  Eva Torreira; Agustín Tortajada; Tamara Montes; Santiago Rodríguez de Córdoba; Oscar Llorca
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-09       Impact factor: 11.205

Review 7.  The alternative pathway of complement.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

8.  Dynamic structural changes during complement C3 activation analyzed by hydrogen/deuterium exchange mass spectrometry.

Authors:  Michael C Schuster; Daniel Ricklin; Krisztián Papp; Kathleen S Molnar; Stephen J Coales; Yoshitomo Hamuro; Georgia Sfyroera; Hui Chen; Michael S Winters; John D Lambris
Journal:  Mol Immunol       Date:  2008-05-05       Impact factor: 4.407

9.  The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase.

Authors:  M K Pangburn; H J Müller-Eberhard
Journal:  Biochem J       Date:  1986-05-01       Impact factor: 3.857

10.  The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb).

Authors:  Fredrik Bexborn; Per Ola Andersson; Hui Chen; Bo Nilsson; Kristina N Ekdahl
Journal:  Mol Immunol       Date:  2007-12-21       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.